Valuation: Becton, Dickinson and Company

Market Cap 48.17B 41.67B 38.91B 35.7B 67.14B 4,585B 68.21B 457B 179B 2,298B 181B 177B 7,597B P/E 2026 *
34.3x
P/E 2027 * 21.4x
Enterprise Value 63.82B 55.2B 51.55B 47.29B 88.95B 6,074B 90.36B 605B 237B 3,044B 240B 234B 10,064B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 3.14x
Free-Float
73.18%
Yield 2026 *
2.22%
Yield 2027 * 2.25%
1 day-0.12%
1 week+6.79%
Current month+6.79%
1 month+13.15%
3 months+15.40%
6 months-15.79%
Current year-8.87%
1 week 166.8
Extreme 166.8
179.4
1 month 148.23
Extreme 148.23
179.4
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
284.48
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap.
8/6/26 Free

Director

189 0.0001%
8/6/26 Free

Director

94 0.0000%
7/27/26 Sell

Executive/Senior Manager

-75 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%+6.79%-5.77%-35.74% 48.17B
-0.14%+2.00%-18.36%-0.59% 187B
+1.44%+2.07%-4.47%+2.88% 112B
-1.40%+2.93%+15.11%+71.75% 61.15B
+0.65%+3.91%+37.08%+53.44% 54.39B
+2.08%+1.56%+10.93%-29.94% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+47.20%-6.50% 24.92B
+2.45%+3.97%+0.52%+4.99% 23.14B
+2.64%+2.11%-6.21%+6.72% 22.2B
Average +1.13%+1.52%+8.45%+7.45% 59.5B
Weighted average by Cap. +0.61%+2.02%+0.24%+8.74%

Financials

2026 *2027 *
Net sales 19.27B 16.67B 15.57B 14.28B 26.86B 1,834B 27.29B 183B 71.69B 919B 72.37B 70.78B 3,039B 19.72B 17.06B 15.93B 14.61B 27.49B 1,877B 27.92B 187B 73.36B 941B 74.06B 72.44B 3,110B
Net income 1.35B 1.17B 1.09B 1B 1.88B 128B 1.91B 12.79B 5.02B 64.4B 5.07B 4.96B 213B 2.16B 1.87B 1.75B 1.6B 3.02B 206B 3.06B 20.51B 8.05B 103B 8.13B 7.95B 341B
Net Debt 15.65B 13.53B 12.64B 11.59B 21.81B 1,489B 22.15B 148B 58.2B 746B 58.75B 57.46B 2,467B 13.84B 11.97B 11.18B 10.26B 19.29B 1,318B 19.6B 131B 51.49B 660B 51.98B 50.85B 2,183B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-08-07 $176.86 -0.12% 1,852,007
26-08-06 $177.07 +3.76% 3,297,360
26-08-05 $170.66 +0.32% 2,538,061
26-08-04 $170.12 -0.05% 2,104,812
26-08-03 $170.21 +2.77% 1,727,639
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
176.86USD
Average target price
189.58USD
Spread / Average Target
+7.19%

Quarterly revenue - Rate of surprise